Equity benchmarks remained under pressure amid consolidation, tracking subdued global cues. Investors await outcome of GST Council meet and SBI earnings later today.
The 30-share BSE Sensex was down 58.78 points at 33,192.15 and the 50-share NSE Nifty fell 19.60 points to 10,289.40.
Drug firm Aurobindo Pharma today reported a 28.96 percent rise in its consolidated net profit to Rs 780.97 crore for the September quarter of the current fiscal mainly on account of robust sales in the US and European Union.
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co
You may also like:
|Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited||Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed|